skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Long-term management of chronic immune thrombocytopenic purpura in adults

Review

(2796) Views  (687) Full article downloads

Authors: Javier Palau, Isidro Jarque, Miguel A Sanz

Published Date September 2010 Volume 2010:3 Pages 305 - 311
DOI: http://dx.doi.org/10.2147/IJGM.S4722

Javier Palau, Isidro Jarque, Miguel A Sanz
Department of Hematology, Hospital Universitario La Fe, Valencia, Spain

Abstract: Chronic immune thrombocytopenic purpura (ITP) is generally a more benign disease than previously thought. Currently it is recommended that only those patients with severe and/or symptomatic thrombocytopenia definitely require treatment. Additional factors, such as age, lifestyle, and uremia can also influence the hemorrhagic risk and should be carefully assessed before decision-making on the appropriate management of patients with less severe forms of ITP. The recent introduction of new classes of therapeutic agents such as rituximab and the thrombopoietic growth factors has had a major impact on the management of ITP. Updated treatment guidelines have recently been made available but they are based largely on expert opinion rather than on high-quality clinical trial evidence. This structured review is focused on the management of adults with chronic ITP, including the use of new classes of agents.

Keywords: corticosteroids, splenectomy, romiplostim, eltrombopag, rituximab






Readers of this article also read:

Current and novel antibiotics against resistant Gram-positive bacteria
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial
Sex ratio of newborn infants born to pregnant women with severe chronic constipation
Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4
Neuropeptide Y level in paraventricular nucleus of experimental diabetic rats: correlation with sympathetic activity and body weight
Types of neural guides and using nanotechnology for peripheral nerve reconstruction
Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats
Amino acid management of Parkinson’s disease: a case study
Seroprevalence of IgG anti-Toxocara species antibodies in a population of patients with suspected allergy
Resistance to antimicrobial drugs in Ghana
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University